ABOUT US

Instagram Links

Come in from Instagram and connect with the webpage of your choice

Read our latest blog post on how customized 3D bioreactors are essential in producing the huge numbers of cells needed to satisfy the global, fast-growing demands of biopharma and advanced therapies. Using 3D printing as part of the Antleron toolbox, we enable bioprocess solutions by developing customized fixed beds that result in scalable and sustainable cell processing => https://bit.ly/3uJUkQs

 

 

To read our newest blogpost on how Antleron applies 3D printing in its R&D projects => https://bit.ly/3IWhwP0

https://www.antleron.com/post/additive-manufacturing-enabling-custom-bioprocess-solutions

 

The flanders.healthTech cluster launched 14 innovative healthcare projects funded a total of €4.7 million by VLAIO. With the Biodevice-CRO partnership – a co-creation between Comate Engineering & Design - Antleron - ICsense – we are developing a biodevice toolbox for rapid development of customized, scalable bioprocess solutions for cell, gene, and diagnostics companies.

 

Antleron CEO Jan Schrooten and VUB professor Heidi Ottevaere are featured in the 20th issue of ‘Economie werkt’, the magazine of the Provincie Vlaams-Brabant. Read article => bit.ly/3tMVx7D

 

Antleron will again co-organize the Life-on-Chip conference => https://bit.ly/31Zv90A

 

ATMP Regulatory Documents blogpost: 
Watch teaser video => https://youtu.be/xR8PpGgfQKA
Read blogpost => http://bit.ly/38J0N06

Cell by Design® (CbD) is featured in the October/November 2021 issue of the GMP Journal (issue 32 page 23)

PDF of Cell by Design in GMP Journal issue 32 => https://bit.ly/3IBxcIM  

Cell by Design page on Antleron website => https://bit.ly/3iK1FHa  

PDF of GMP Journal issue 32 => https://bit.ly/3y9r5X4  

GMP Journal (all digital issues) => https://bit.ly/31O0Ol1  

Cell by Design in GMP Journal (online version) => https://bit.ly/3dGmXEx 

 

 

Jan Schrooten speaks at online M3d+it symposium about ‘3D-Printing-by-Design for next-gen life science applications’ => https://bit.ly/3FXqTNm

Antleron in silico simulations driven by Ansys solutions => https://bit.ly/30orRmZ

 

Antleron, QbD, Novadip and Ospin to speak at the ‘Closed Systems : Disruptive solution for Aseptic Processes’ Forum A3P Belgium in Liege on October 28. => https://bit.ly/3itv6Pu

 

Antleron and VivaBioCell collaborate to enable sustainable cell therapy manufacturing through innovative bioreactor solutions. => https://bit.ly/3aT5A2b

X-Pure®–by-design illustrates that our Antleron-Rousselot® collaborative-development partnership enables both parties to reach further together => https://bit.ly/3mNmOmT

Join Antleron & QbD at the ‘Closed Systems : Disruptive solution for Aseptic Processes’ Forum A3P Belgium in Liege on October 28. => https://bit.ly/3itv6Pu

 

Recently we introduced the Quality by Design methodology to enable sustainable ATMP development and scalable manufacturing. 

 

 

Today we are happy to present the newest white paper co-written by our in-house expert Evan Claes and Johan van den Bergh of QbD.

Read about how bringing together Quality by Design and Process Analytical Technology facilitates users in making data and risk driven decisions, resulting in robust processes for ATMP manufacturing. 



On the upcoming Knowledge for Growth conference, Antleron CEO Jan Schrooten will moderate 'The Power of Cell & Gene' session in the 'Personalized Medicine' track. It will be an inspiring session with speakers/panelists Michael Linden (Handl Therapeutics), Pieter Rottiers (Precigen ActoBio), Steven Powell (eTheRNA) and Erwin Blomsma (ViroVet). => 


Read more about Quality-by-Design (QbD) and how Antleron employs it across its R&D projects to more effectively reach optimal and robust results => https://bit.ly/37C6q1J